Anti-TNBC effects of Lappaol F by targeting epithelial-mesenchymal transition via regulation of GSK-3β/YAP/β-catenin and PI3K/AKT pathways

Anti-TNBC effects of Lappaol F by targeting epithelial-mesenchymal transition via regulation of GSK-3β/YAP/β-catenin and PI3K/AKT pathways

PurposeLappaol F (LAF), a lignan extracted from Fructus Arctii, has a wide spectrum of anti-tumor effects, including inhibition of TNBC cell growth. However, the pharmacological mechanism of LAF targeting epithelial-mesenchymal transition (EMT) to inhibit Triple-negative breast cancer (TNBC) growth...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qiqi Meng, Zhiping Li, Xiaofeng He, Yuanhao Hu, Guiyun Wu, Jiawen Huang, Zhuohui Luo, Yingjie Hu, Xiaoling Shen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Pharmacology
Subjects:	Arctium lappa L Lappaol F triple negative breast cancer epithelial-mesenchymal transition GSK-3β/YAP/β-catenin signaling PI3K/AKT signaling
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1496511/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ROLE OF GSK-3 IN Wnt/β-CATENIN SIGNALING PATHWAY IN OBESITY
by: A. S. Kulakova, et al.
Published: (2021-10-01)

SCFβ-TrCP targets Ajuba for degradation in a GSK3β-dependent manner in colorectal cancer
by: Liangshan Li, et al.
Published: (2025-08-01)

Different activation of MAPKs and Akt/GSK3β after preload vs. afterload elevation
by: Nico Hartmann, et al.
Published: (2022-06-01)

东北林蛙GSK3β基因荧光定量PCR引物筛选体系的建立
by: 张宇巩珊珊柴龙会张晶钰肖向红
Published: (2016-01-01)

RRP9 promotes prostate cancer metastasis and epithelial-mesenchymal transition through activation of the AKT/GSK3β/β-Catenin signaling pathway
by: Zijian Da, et al.
Published: (2025-06-01)

Hyptolide induces ER stress-mediated cell death and enhances GSK3β-regulated cisplatin chemosensitivity in ovarian cancer
by: Yusi Luluk Rahmania, et al.
Published: (2025-06-01)

MAPK, PI3K/Akt Pathways, and GSK-3β Activity in Severe Acute Heart Failure in Intensive Care Patients: An Updated Review
by: Massimo Meco, et al.
Published: (2025-07-01)

miR-32-5p suppresses the progression of hepatocellular carcinoma by regulating the GSK3β/NF-κB signaling
by: Wang Guangzhi, et al.
Published: (2025-04-01)

Epibrassinolide Triggers Apoptotic Cell Death in SK-N-AS Neuroblastoma Cells by Targeting GSK3β in a ROS Generation-Dependent Way
by: Pınar Obakan Yerlikaya, et al.
Published: (2022-12-01)

Traditional Chinese medicine in Alzheimer's disease: From the perspective of GSK-3β and Tau hyperphosphorylation
by: Mei Wang, et al.
Published: (2024-12-01)

Natural bioactive compounds form herbal medicine in Alzheimer’s disease: from the perspective of GSK-3β
by: Mei Wang, et al.
Published: (2025-02-01)

Emodin promotes GSK-3β-mediated PD-L1 proteasomal degradation and enhances anti-tumor immunity in hepatocellular carcinoma
by: Xuemei Yang, et al.
Published: (2025-08-01)

Cerasus humilis Proanthocyanidins Ameliorats Insulin Resistance through PI3K-Akt-GSK-3β Signaling Pathway in HepG2 Cells
by: Xinhui LIU, et al.
Published: (2025-04-01)

Elucidation of Artemisinin as a Potent GSK3β Inhibitor for Neurodegenerative Disorders via Machine Learning-Driven QSAR and Virtual Screening of Natural Compounds
by: Hassan H. Alhassan, et al.
Published: (2025-05-01)

Assessing the Role of GSK3 β and Arrestin Beta1 in Regulating Oxidative Stress that Causes Metabolic Disorders
by: Asmaa Abd, et al.
Published: (2025-03-01)

The Effects of Xenon on GSK-3β, NF-κB, and Nrf2 Levels in the Rat Brain: An Experimental Study
by: E. E. Beda, et al.
Published: (2025-06-01)

Electroacupuncture regulates ferroptosis to improve postoperative cognitive dysfunction in mice through mediating GRX1/GSK-3β/Nrf2 axis
by: Xiaqing Zhang, et al.
Published: (2025-03-01)

Effects of <italic>Cistanche Deserticola</italic> on Behavior and Expression of GSK-3β in Hippocampus of Rat Model of Parkinson's Disease
by: Shasha YANG, et al.
Published: (2016-12-01)

Cytotoxic Activity of Arctium lappa L. Fractions on Breast Cancer Cells (MCF-7, MDA-MB-231)
by: Mahdieh Samei, et al.
Published: (2025-04-01)

RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer’s Disease
by: Milan M. Medd, et al.
Published: (2025-02-01)

Computational analysis of zoanthamine alkaloids from Zoanthus sp. as potential DKK1 and GSK-3β inhibitors for osteoporosis therapy via Wnt signaling
by: Ngoc-Thac Pham, et al.
Published: (2025-04-01)

GAS reduced inflammatory responses in activated microglia by regulating the Ccr2/Akt/Gsk-3β pathway
by: Haolong Shi, et al.
Published: (2025-05-01)

Danggui Shaoyao San Alleviates Early Cognitive Impairment in Alzheimer's Disease Mice Through IRS1/GSK3β/Wnt3a‐β‐Catenin Pathway
by: Kai‐Xin Zhang, et al.
Published: (2024-10-01)

Evaluation of the metabolic activity, angiogenic impacts, and GSK-3β signaling of the synthetic cannabinoid MMB-2201 on human cerebral microvascular endothelial cells
by: Laith Naser AL-Eitan, et al.
Published: (2024-12-01)

miR-1246 enhances chemo-resistance of polyploid giant cancer cells in H1299 cells by targeting GSK3β/β-catenin
by: Lili Wang, et al.
Published: (2025-05-01)

CCN1 stimulated the osteoblasts via PTEN/AKT/GSK3β/cyclinD1 signal pathway in Myeloma Bone Disease
by: Siyang Yan, et al.
Published: (2020-01-01)

Early dysregulation of GSK3β impairs mitochondrial activity in Fragile X Syndrome
by: Giulia Cencelli, et al.
Published: (2024-12-01)

The umbilical cord blood exosome MFG-E8 alleviates hypoxic-ischemic encephalopathy brain injury in neonatal rats by restoring autophagy flux and inhibiting ferroptosis through GSK3β/β-catenin signaling
by: Menghua Zhao, et al.
Published: (2025-12-01)

Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer’s disease
by: Ning Yan, et al.
Published: (2022-12-01)

Association of MiRNA Polymorphisms Involved in the PI3K/ATK/GSK3β Pathway with T2DM in a Chinese Population
by: Zhou X, et al.
Published: (2025-02-01)

Apigenin ameliorates CCl4-induced hepatic fibrosis by inhibiting hepatic stellate cell activation via PI3K/AKT/GSK3β pathway in mice
by: Tao Sun, et al.
Published: (2025-04-01)

VP3.15, a dual GSK-3β/PDE7 inhibitor, reduces glioblastoma tumor growth though changes in the tumor microenvironment in a PTEN wild-type context
by: Maria Castello-Pons, et al.
Published: (2025-07-01)

Effect of Xenon on the Phosphorylation of Glycogen Synthase Kinase 3β and Antioxidant Enzymes in Rat Brain
by: A. N. Kuzovlev, et al.
Published: (2021-01-01)

Salidroside alleviates Aβ1–42-induced ferroptosis in human neuroblastoma cells by AKT/GSK-3β activation via inhibiting VDAC1
by: Bensi Zhang, et al.
Published: (2025-08-01)

BMAL1 ameliorates type 2 diabetes-induced cognitive impairment via AREG upregulation and PI3K/Akt/GSK-3β pathway activation
by: Jialu Xu, et al.
Published: (2025-01-01)

Dual GSK-3β/HDAC Inhibitors Enhance the Efficacy of Macrophages to Control <i>Mycobacterium tuberculosis</i> Infection
by: Sadaf Kalsum, et al.
Published: (2025-04-01)

Anti-leishmanial effect of the hydroalcoholic extract of the leaves, roots and seeds of Arctium lappa
by: Elham Maleki, et al.
Published: (2025-03-01)

Hepatotoxic Test Of Burdock Roots (Arctium Lappa L) On Histopathology Hepar Of Male White Rats (Rattus Norvegicus
by: Atika Nur Wigati, et al.
Published: (2024-12-01)

Preparation and characterization of Arctium lappa L. polysaccharide-Zn(II) complex and evaluation of its immune activity
by: Yang Liu, et al.
Published: (2024-12-01)

CD9 regulates proliferation, invasion, migration and radioresistance of esophageal squamous cell carcinoma by activating AKT/GSK3β signaling pathway
by: Liubing Hou, et al.
Published: (2025-08-01)